Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib Access for CML Patients from ENACT in Poland
NCT01368523Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nilotinib in chronic myeloid leukemia (CML), sponsored by Novartis. Started Dec 2008; status: completed.
02
Drugs
nilotinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT01368523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01368523.